Detailed Information on Publication Record
2002
An association of BMI with and A(-6)G, M235T and T174M polymorphisms in angiotensinogen gene in essential hypertension
VAŠKŮ, Anna, Miroslav SOUČEK, Svatava TSCHÖPLOVÁ and Andrea STEJSKALOVÁBasic information
Original name
An association of BMI with and A(-6)G, M235T and T174M polymorphisms in angiotensinogen gene in essential hypertension
Authors
VAŠKŮ, Anna (203 Czech Republic, guarantor), Miroslav SOUČEK (203 Czech Republic), Svatava TSCHÖPLOVÁ (203 Czech Republic) and Andrea STEJSKALOVÁ (203 Czech Republic)
Edition
Journal of Human Hypertension, Velká Británie, Nature Publishing Group, 2002, 0950-9240
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30201 Cardiac and Cardiovascular systems
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.366
RIV identification code
RIV/00216224:14110/02:00005721
Organization unit
Faculty of Medicine
UT WoS
000176625500010
Keywords in English
BMI; obesity; essential hypertension; angiotensinogen; gene polymorphism; and smoking; risk factor
Tags
Změněno: 18/6/2009 09:56, prof. MUDr. Anna Vašků, CSc.
Abstract
V originále
The aim of the study was to assess the existence of possible associations among frequent polymorphism in angiotensinogen gene and some risk factors for essential hypertension, especially BMI and smoking. 192 control subjects (age 45.87+/-3.0) and 206 patients with the essential hypertension (age 48.71+/- 8.42) were compared at three angiotensinogen gene polymorphisms considering BMI and smoking status. No significant differences in genotype and/or allelic distribution for either A (-6) G ATG or M235T or T174M polymorphisms between the hypertensive and control groups were proved. Significantly more hypertensives than control persons with BMI above 25 kg/m2 were observed (Pcorr=0.009), independently on sex distribution. 44.6% of smokers in control group vs. 46.0% of smokers in hypertensive groups were found. No significant difference in concurrence of BMI above 25 kg/m2 and positive smoking status between control and hypertensive subjects was found. Statistically significant differences were found between control and hypertensive subjects when compared distributions of subjects with certain genotypes of the three examined polymorphisms considering BMI (Pcorr=0.0002 for AA+AG of A(-6)G ATG, Pcorr= 0.01 for CC+CT of T(174)M ATG and Pcorr=0.01 for MT+TT of M235T ATG). No functional relations among obesity and the examined polymorphisms in vivo are known. We conclude that different distribution of BMI could influence results of analyses of angiotensinogen gene polymorphisms in essential hypertension-control studies.
Links
GA306/93/2192, research and development project |
| ||
GA306/96/0099, research and development project |
| ||
MSM 141100002, plan (intention) |
|